<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 04 Jun 2026 15:01:16 -0400--><rss version="2.0">
    <channel>
        <title>RenovoRX, Inc. (RNXT) Press Releases</title>
        <link>https://ir.renovorx.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/renovorx/files/theme/images/logo-sm.png</url>
                <title>RenovoRX, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/165/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha</link>
                <pubDate>Thu, 04 Jun 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/165/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/164/renovorx-announces-fda-orphan-drug-designation-granted</link>
                <pubDate>Thu, 28 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/164/renovorx-announces-fda-orphan-drug-designation-granted</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/163/renovorx-announces-promising-pharmacokinetic-data-using-the</link>
                <pubDate>Tue, 26 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/163/renovorx-announces-promising-pharmacokinetic-data-using-the</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/162/renovorx-to-present-at-the-alliance-global-partners-virtual</link>
                <pubDate>Tue, 19 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/162/renovorx-to-present-at-the-alliance-global-partners-virtual</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/161/renovorx-reports-record-first-quarter-2026-increasing</link>
                <pubDate>Thu, 14 May 26 16:05:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/161/renovorx-reports-record-first-quarter-2026-increasing</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/160/renovorx-to-host-first-quarter-2026-financial-results-and</link>
                <pubDate>Wed, 29 Apr 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/160/renovorx-to-host-first-quarter-2026-financial-results-and</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/159/renovorx-announces-pharmacokinetic-and-pharmacodynamic-data</link>
                <pubDate>Thu, 23 Apr 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/159/renovorx-announces-pharmacokinetic-and-pharmacodynamic-data</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/158/clinical-data-supporting-targeted-chemotherapeutic-delivery</link>
                <pubDate>Tue, 14 Apr 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/158/clinical-data-supporting-targeted-chemotherapeutic-delivery</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/157/renovorx-secures-first-notice-of-allowance-for-japanese</link>
                <pubDate>Wed, 08 Apr 26 08:30:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/157/renovorx-secures-first-notice-of-allowance-for-japanese</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.renovorx.com/news-events/press-releases/detail/156/renovorx-named-to-fast-companys-annual-list-of-the</link>
                <pubDate>Wed, 01 Apr 26 14:20:00 -0400</pubDate>
                <guid>https://ir.renovorx.com/news-events/press-releases/detail/156/renovorx-named-to-fast-companys-annual-list-of-the</guid>
                                                                            </item>
            </channel>
</rss>